1. Ajmera A, Shabbir N. Salmonella. In: StatPearls. StatPearls Publishing; 2023. Accessed December 25, 2023. http://www.ncbi.nlm.nih.gov/books/NBK555892/
2. Chatterjee R, Chowdhury AR, Mukherjee D, Chakravortty D. From Eberthella typhi to Salmonella Typhi: The Fascinating Journey of the Virulence and Pathogenicity of Salmonella Typhi.
ACS Omega. 2023;8(29):25674-25697.
3. Barnett R. Typhoid fever. The Lancet. 2016;388(10059):2467.
4. Andrews JR, Harris JB, Ryan ET. Typhoid Fever, Paratyphoid Fever, and Typhoidal Fevers. In: Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 9th edition,
Philadelphia: Elsevier; 2020: 1365-1379.
5. Multi-country outbreak of Salmonella Typhimurium linked to chocolate products – Europe and the United States of America. Accessed December 26, 2023. https://www.who.int/emergencies/
disease-outbreak-news/item/2022-DON369
6. Brenner FW, Villar RG, Angulo FJ, Tauxe R, Swaminathan B. Salmonella Nomenclature. J Clin Microbiol. 2000;38(7):2465-2467.
7. Shaji S, Selvaraj RK, Shanmugasundaram R. Salmonella Infection in Poultry: A Review on the Pathogen and Control Strategies. Microorganisms. 2023;11(11):2814.
8. Ashurst JV, Truong J, Woodbury B. Typhoid Fever (Salmonella Typhi). In: StatPearls. StatPearls Publishing; 2023. Accessed December 27, 2023. http://www.ncbi.nlm.nih.gov/books/
NBK519002/
9. Johnson R, Mylona E, Frankel G. Typhoidal Salmonella: Distinctive virulence factors and pathogenesis. Cell Microbiol. 2018;20(9):e12939.
10. Bhandari J, Thada PK, DeVos E. Typhoid Fever. In: StatPearls. StatPearls Publishing; 2023. Accessed December 28, 2023. http://www.ncbi.nlm.nih.gov/books/NBK557513/
11. Typhoid & Paratyphoid Fever | CDC Yellow Book 2024. Accessed December 28, 2023. https://wwwnc.cdc.gov/travel/yellowbook/2024/infections-diseases/typhoid-and-paratyphoid-fever
12. Stanaway JD, Reiner RC, Blacker BF, et al. The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Infect Dis.
2019;19(4):369-381.
13. Kaya N, Şahinöz T. Bulaşıcı Hastalık Bildirimlerinin Afet Yönetimi Açısından İncelenmesi. Gümüşhane Üniversitesi Sağlık Bilim Derg. 2021;10(1):21-31.
14. Ozdemir R, Kayatas E. Typhoid epidemic in Hakkari – March 2007: Evaluation of affected pediatric patients. J Dr Behcet Uz Child Hosp. 2012;2(3):137-140.
15. Moudgil KD, Narang BS. Pathogenesis of typhoid fever. Indian J Pediatr. 1985;52(4):371-378.
16. Crump JA, Sjölund-Karlsson M, Gordon MA, Parry CM. Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive
Salmonella Infections. Clin Microbiol Rev. 2015;28(4):901-937.
17. Parry CM, Hien TT, Dougan G, White NJ, Farrar JJ. Typhoid Fever. N Engl J Med. 2002;347(22):1770-1782.
18. Netea MG, Radstake T, Joosten LA, van der Meer JW, Barrera P, Kullberg BJ. Salmonella Septicemia in Rheumatoid Arthritis Patients Receiving Anti-Tumor Necrosis Factor Therapy: Asso-
ciation With Decreased Interferon-gamma Production and Toll-Like Receptor 4 Expression. Arthritis Rheum. 2003 Jul;48(7):1853-7.
19. Tagliabue A, Nencioni L, Caffarena A, et al. Cellular immunity against Salmonella typhi after live oral vaccine. Clin Exp Immunol. 1985;62(2):242-247.
20. Neupane DP, Dulal HP, Song J. Enteric Fever Diagnosis: Current Challenges and Future Directions. Pathogens. 2021;10(4):410.
21. Mawazo A, Bwire GM, Matee MIN. Performance of Widal test and stool culture in the diagnosis of typhoid fever among suspected patients in Dar es Salaam, Tanzania. BMC Res Notes.
2019;12:316.
22. Parry CM, Hoa NT, Diep TS, et al. Value of a single-tube widal test in diagnosis of typhoid fever in Vietnam. J Clin Microbiol. 1999;37(9):2882-2886.
23. Mahmoud A, Oluyemisi A, Uwishema O, et al. Recent advances in the diagnosis and management of typhoid fever in Africa: A review. Int J Health Plann Manage. 2023;38(2):317-329.
24. Cohen R, Babushkin F, Shapiro M, Uda M, Atiya-Nasagi Y, Finn T. Case Report: Typhoid Fever and Spotted Fever Group Rickettsiosis Presenting Concomitantly in an Indian Immigrant. Am
J Trop Med Hyg. 2018;99(4):864-866.
25. Klemm EJ, Shakoor S, Page AJ, et al. Emergence of an Extensively Drug-Resistant Salmonella enterica Serovar Typhi Clone Harboring a Promiscuous Plasmid Encoding Resistance to Fluo-
roquinolones and Third-Generation Cephalosporins. mBio. 2018;9(1):10.1128/mbio.00105-18.
26. Extensively Drug-Resistant Typhoid Fever in Pakistan – Level 1 – Level 1 – Practice Usual Precautions – Travel Health Notices | Travelers’ Health | CDC. Accessed January 10, 2024. https://
wwwnc.cdc.gov/travel/notices/level1/xdr-typhoid-fever-pakistan
27. Zhou K, Sun L, Zhang X, et al. Salmonella antimicrobials inherited and the non-inherited resistance: mechanisms and alternative therapeutic strategies. Front Microbiol. 2023;14.
28. Wain J, Diep TS, Ho VA, et al. Quantitation of Bacteria in Blood of Typhoid Fever Patients and Relationship between Counts and Clinical Features, Transmissibility, and Antibiotic Resistance.
J Clin Microbiol. 1998;36(6):1683-1687.
29. Crump JA, Kretsinger K, Gay K, et al. Clinical Response and Outcome of Infection with Salmonella enterica Serotype Typhi with Decreased Susceptibility to Fluoroquinolones: a United States
FoodNet Multicenter Retrospective Cohort Study. Antimicrob Agents Chemother. 2008;52(4):1278-1284.
30. Effa EE, Lassi ZS, Critchley JA, et al. Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever). Cochrane Database Syst Rev. 2011;2011(10):CD004530.
31. Manesh A, Meltzer E, Jin C, et al. Typhoid and paratyphoid fever: a clinical seminar. J Travel Med. 2021;28(3):taab012.
32. Thaver D, Zaidi AKM, Critchley J, Azmatullah A, Madni SA, Bhutta ZA. A comparison of fluoroquinolones versus other antibiotics for treating enteric fever: meta-analysis. BMJ.
2009;338:b1865.
33. Jin C, Gibani MM, Pennington SH, et al. Treatment responses to Azithromycin and Ciprofloxacin in uncomplicated Salmonella Typhi infection: A comparison of Clinical and Microbiological
Data from a Controlled Human Infection Model. PLoS Negl Trop Dis. 2019;13(12):e0007955.
34. Hoffman SL, Punjabi NH, Kumala S, et al. Reduction of Mortality in Chloramphenicol-Treated Severe Typhoid Fever by High-Dose Dexamethasone. N Engl J Med. 1984;310(2):82-88.
35. Koshiol J, Wozniak A, Cook P, et al. Salmonella enterica serovar Typhi and gallbladder cancer: a case–control study and meta-analysis. Cancer Med. 2016;5(11):3310-3235.
36. Hoffman SA, Sikorski MJ, Levine MM. Chronic Salmonella Typhi carriage at sites other than the gallbladder. PLoS Negl Trop Dis. 2023;17(3):e0011168.
37. Mermin JH, Villar R, Carpenter J, et al. A Massive Epidemic of Multidrug-Resistant Typhoid Fever in Tajikistan Associated with Consumption of Municipal Water. J Infect Dis. 1999;179(6):1416-
1422.
38. Food & Water Precautions | CDC Yellow Book 2024. Accessed January 15, 2024. https://wwwnc.cdc.gov/travel/yellowbook/2024/preparing/food-and-water-precautions
39. Saha T, Arisoyin AE, Bollu B, et al. Enteric Fever: Diagnostic Challenges and the Importance of Early Intervention. Cureus. 15(7):e41831.
40. Typhoid. Accessed January 15, 2024. https://www.who.int/news-room/fact-sheets/detail/typhoid
41. Milligan R, Paul M, Richardson M, Neuberger A. Vaccines for preventing typhoid fever. Cochrane Database Syst Rev. 2018;2018(5):CD001261.
TİFO DIŞI SALMONELLOZ
KAYNAKLAR
1. Stanaway JD, Parisi A, Sarkar K, et al. The global burden of non-typhoidal salmonella invasive disease: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Infect Dis.
2019;19(12):1312-1324.
2. Pegues DA, Miller SI. Salmonella Species. In: Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 9th edition, Philadelphia: Elsevier; 2020: 2725-2736.
3. Ajmera A, Shabbir N. Salmonella. In: StatPearls. StatPearls Publishing; 2023. Accessed December 25, 2023. http://www.ncbi.nlm.nih.gov/books/NBK555892/
4. Töreci K, Erdem B, Öngen B. Salmonella Serovars Isolated in Turkey Up to the End of Year 2011. Mikrobiyol Bul. 2013;47(3):442-460.
5. Marchello CS, Birkhold M, Crump JA, et al. Complications and mortality of non-typhoidal salmonella invasive disease: a global systematic review and meta-analysis. Lancet Infect Dis.
2022;22(5):692-705.
6. Majowicz SE, Musto J, Scallan E, et al. The Global Burden of Nontyphoidal Salmonella Gastroenteritis. Clin Infect Dis. 2010;50(6):882-889.
7. McDermott PF, Zhao S, Tate H. Antimicrobial Resistance in Nontyphoidal Salmonella. Microbiol Spectr. 2018;6(4):10.1128/microbiolspec.arba-0014-2017.
8. Ao TT, Feasey NA, Gordon MA, Keddy KH, Angulo FJ, Crump JA. Global Burden of Invasive Nontyphoidal Salmonella Disease, 2010. Emerg Infect Dis. 2015;21(6):941-949.
9. Nontyphoidal salmonella disease. Accessed January 18, 2024. https://www.who.int/teams/immunization-vaccines-and-biologicals/diseases/nontyphoidal-salmonella-disease
10. Crump JA, Sjölund-Karlsson M, Gordon MA, Parry CM. Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive
Salmonella Infections. Clin Microbiol Rev. 2015;28(4):901-937.
11. Outbreaks Involving Salmonella | CDC. Published January 5, 2024. Accessed January 18, 2024. https://www.cdc.gov/salmonella/outbreaks.html
12. Fernández J, Guerra B, Rodicio MR. Resistance to Carbapenems in Non-Typhoidal Salmonella enterica Serovars from Humans, Animals and Food. Vet Sci. 2018;5(2):40.
13. Düzgöl M, Kara A, Çağlar İ, ve ark. İzmir‘de Bir Üçüncü Basamak Hastanede İzole Edilen Salmonella Türlerinin Sıkça Kullanılan Antimikrobiyal İlaçlara Olan Duyarlılıkları. J Pediatr Infect.
2017;11(4):171-175.
14. Gündoğdu A, Kilic H, Ulu-Kılıç A, Parkan Ö, Ture Z. Distribution and Antimicrobial Resistance of Salmonella Serovars Isolated in Kayseri Region. Klimik Derg. 2017;30:22-26.
15. Jajere SM. A review of Salmonella enterica with particular focus on the pathogenicity and virulence factors, host specificity and antimicrobial resistance including multidrug resistance. Vet
World. 2019;12(4):504-521.
16. Dudhane RA, Bankar NJ, Shelke YP, Badge AK. The Rise of Non-typhoidal Salmonella Infections in India: Causes, Symptoms, and Prevention. Cureus. 15(10):e46699.
17. Manesh A, Meltzer E, Jin C, et al. Typhoid and paratyphoid fever: a clinical seminar. J Travel Med. 2021;28(3):taab012.
18. Ehrhardt K, Becker AL, Grassl GA. Determinants of persistent Salmonella infections. Curr Opin Immunol. 2023;82:102306.
19. Piccini G, Montomoli E. Pathogenic signature of invasive non-typhoidal Salmonella in Africa: implications for vaccine development. Hum Vaccines Immunother. 2020;16(9):2056-2071.
20. Onwuezobe IA, Oshun PO, Odigwe CC. Antimicrobials for treating symptomatic non‐typhoidal Salmonella infection. Cochrane Database Syst Rev. 2012;2012(11):CD001167.
21. Information for Healthcare Professionals | Salmonella | CDC. Published July 3, 2023. Accessed January 29, 2024. https://www.cdc.gov/salmonella/general/technical.html
22. Tack B, Vanaenrode J, Verbakel JY, Toelen J, Jacobs J. Invasive non-typhoidal Salmonella infections in sub-Saharan Africa: a systematic review on antimicrobial resistance and treatment. BMC
Med. 2020;18:212.
23. Kariuki S, Gordon MA, Feasey N, Parry CM. Antimicrobial resistance and management of invasive Salmonella disease. Vaccine. 2015;33(0 3):C21-C29.
24. Sánchez-Vargas FM, Abu-El-Haija MA, Gómez-Duarte OG. Salmonella infections: An update on epidemiology, management, and prevention. Travel Med Infect Dis. 2011;9(6):263-277.
25. Sirinavin S, Thavornnunth J, Sakchainanont B, Bangtrakulnonth A, Chongthawonsatid S, Junumporn S. Norfloxacin and Azithromycin for Treatment of Nontyphoidal Salmonella Carriers.
Clin Infect Dis. 2003;37(5):685-691.
26. Marchello CS, Fiorino F, Pettini E, et al. Incidence of non-typhoidal Salmonella invasive disease: A systematic review and meta-analysis. J Infect. 2021;83(5):523-532.
27. Teklemariam AD, Al-Hindi RR, Albiheyri RS, et al. Human Salmonellosis: A Continuous Global Threat in the Farm-to-Fork Food Safety Continuum. Foods. 2023;12(9):1756.
28. Shaji S, Selvaraj RK, Shanmugasundaram R. Salmonella Infection in Poultry: A Review on the Pathogen and Control Strategies. Microorganisms. 2023;11(11):2814.
29. Haselbeck AH, Panzner U, Im J, Baker S, Meyer CG, Marks F. Current perspectives on invasive nontyphoidal Salmonella disease. Curr Opin Infect Dis. 2017;30(5):498-503